All
Dean Celia reflects on 40th anniversary of Dermatology Times
September 18th 2019Dean Celia, our original managing editor, reflects the beginning of Dermatology Times and the medical editors, Dr. Ronald Wheeland and Dr. Norman Levine, who ensured the publication focused on the key industry developments that mattered most to practicing dermatologists.
FDA accepts new drug application for tazarotene lotion
August 19th 2019The U.S. Food and Drug Administration (FDA) accepted a new drug application (NDA) for Ortho Dermatologics’ novel tazarotene O.045% lotion (IDP-123) with a PDUFA action date of Dec. 22, 2019, according a recent announcement from the company.
Powerful immunosuppressant agents predispose patients to fungal infections
July 26th 2019Patients on powerful immunocompromising agents might be predisposed to infections; however the potential association between biologic agents and increased risk isn’t necessarily universal, Whitney High, M.D., reported during the summer meeting of the American Academy of Dermatology.